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It is almost thirty years since Barker first highlighted the importance of prenatal factors in 
contributing to the developmental origins of adult disease. This concept was later broadened to 
include postnatal events. It is clear that the interaction between genetic predisposition and early 
life environmental exposures are key in this regard. However, recent research has also identified 
another important factor in the microbiota, the trillions of microorganisms that inhabit key body 
niches including the vagina and gastrointestinal tract. Since the composition of these maternal 
microbiome sites have been linked to maternal metabolism and are also vertically transmitted to 
offspring, changes in the maternal microbiota are poised to significantly impact on the newborn. 
In fact, several lines of evidence show that the gut microbiota interacts with diet, drugs and stress 
both prenatally and postnatally and that these exogn us factors could also impact the dynamic 
changes in the microbiota composition occurring during pregnancy. Animal models have shown 
great utility in illuminating how these disruptions result in behavioral and brain morphological 
phenotypes reminiscent of psychiatric disorders (anxiety, depression, schizophrenia, autism-
spectrum disorders). Increasing evidence points to critical interactions between the microbiota, 
host genetics and both the prenatal and postnatal environment to temporally program 
susceptibility to psychiatric disorders later in life. Sex-specific phenotypes may be programmed 



















1.0 Building on Barker: Four Hit Hypothesis for Development of Disease 
Studies on the developmental origins of health and disease have gleaned mechanistic insights as 
well as risk factors that impact development. Using lar e cohort studies, Dr. David Barker 
showed that low birth weight was a risk factor for ca diac disease and ischemia (1-4). He 
postulated that factors affecting the fetus, pre- and early postnatal environment, and genetic 
predisposition, programmed health and disease in adulthood (1-4). Disruptions of any of these 
factors will function as a “hit” towards disease, and multiple “hits” may interact and increase the 
magnitude of impact of these factors. Current research in neuroscience, physiology and 
immunology has now shown that the human microbiota, referring to the individual 
microorganisms, and the microbiome, their collective genomes (5-7), play an important role in 
health and disease; thus the microbiota could act as a fourth “hit”. The gut and vaginal 
microbiota is both affected by, and can act upon, these other factors in Barker’s hypothesis, 
showing integrative functionality in the programming of health and disease (see Figure 1).  
The vaginal and gut maternal microbiome has been a r cent focus for understanding the health 
and disease in offspring. In fact, there is evidence of universal vertical microbiota transmission 
between mother and offspring in all animals (8). There is further interest in the study of the 
maternal microbiota to elucidate its roles in mediating the impact of prenatal factors, such as diet 
and pharmacological agents, on the offspring. During early development, the infant microbiota 
may also be vulnerable to shaping from similar postnatal exposures. Thus, one of the emerging 
questions in developmental psychopathology research is how might the maternal vaginal and gut 
microbiota interact with prenatal and postnatal environment, and host genetics to program brain 















For the purposes of this review, the programming of brain health refers to physiological, 
transcriptional or epigenetic changes induced by prenatal environment or exposure to compounds 
that lead to altering the homeostatic set point for neurodevelopment in the first 1000 days of 
human life or the animal model equivalent (9). With a focus on bacteria, we describe how 
pregnancy-related changes in the composition of the maternal microbiota as well as changes in 
the microbiota during early postnatal life may interact with host genetics, prenatal and early life 
environment to affect brain health.  During fetal development as well as early life, critical 
periods exist where both negative and positive interventions could alter the trajectory of 
neurodevelopment and impact brain health later in life (see Figure 2).  
2.0 The Microbiota  
The human gut microbiota, consisting of trillions of bacteria and weighing approximately 400 
grams (10), and their genomes, have profound impact on physiology and behavior. It is the most 
well-characterized mammalian microbiome and is involved in modulating intestinal barrier 
permeability as well as gut-brain axis signaling through the vagal nerve, inflammatory 
molecules, endocrine molecules, and microbial metabolites (11-14). The brain-gut-microbiota 
axis includes components of the central nervous system, the neuroendocrine and  neuroimmune 
systems as well as components of the autonomic and enteric nervous system (15). However, 
many of the mechanisms underlying this axis remain unknown. 
Other areas of the body which host a bacterial community include the skin, oral cavity, 
conjunctiva, lungs, biliary duct, the vagina and possibly the placenta. During pregnancy, the 
communities in many body areas change, but most focus has been placed on the remodeling that 















determine the amount of different types of bacteria as well as their relative abundances within a 
community. 
 
2.1 Human Microbiota During Pregnancy 
2.1.1 Gut Microbiota 
During pregnancy, the human gut microbiome undergoes dynamic compositional changes, which 
accompany changes in metabolism (16-19). As gestation progresses, intestinal microbiota 
diversity, and specifically Proteobacteria and Actinobacteria increase (17). As a result, the gut 
microbiota composition during the third trimester is s gnificantly different from its composition 
at the beginning of pregnancy (17). Gut microbial dversity has also been shown to increase 
postpartum in the mother and vaginally-delivered newborns (17, 20, 21). Interestingly, germ-free 
mice that received a transplantation of human microbiota from the third trimester of pregnancy 
displayed symptoms of metabolic syndrome – increased diposity, inflammation and reduced 
glucose tolerance (17-19).  These effects may be mediated by key gut microbial metabolites such 
as short-chain fatty acids, which were previously shown to be associated with these metabolic 
changes during pregnancy (16). Since most changes i the gut microbiota occur in the second 
and third trimester, perhaps microbiota modulation during these critical time periods can impact 
neurodevelopment.  
2.1.2 Vaginal Microbiota 
The human vaginal microbiome consists of multiple stable community state types, which 
destabilize during pregnancy (22, 23). It is most abundant in Lactobacillus spp. before 















studies found concurrent reduction in overall bacterial diversity during pregnancy (26) while 
others did not (24, 25). In addition, postpartum bacterial diversity was found to be increased (25) 
Notably, there are also differences in the composition of the vaginal microbiome during 
pregnancy and postpartum between different ethnic groups suggesting an interaction between 
bacterial colonization and host genetics and enviroment (25). The infant gut microbiome most 
closely resembles the vaginal microbiome of the mother, which initially colonize the infant, 
consistent with patterns of vertical transmission across the animal kingdom (8, 27, 28).  
2.2 Pregnancy Related Changes in the Microbiota: Preclinical Models 
2.2.1 Intestinal Microbiota 
The intestinal microbiota in mouse models also undergo s compositional changes during 
pregnancy, affecting maternal metabolism. While taxa from the Firmicutes and Tenericute phyla 
decrease in composition (29, 30), there is an increase in the circulation of short-chain fatty acids 
produced by other members of the microbiota along with tissue-specific transcriptional changes 
in its receptor, free fatty acid receptor 2 (29). Interestingly, mice deficient in this receptor 
experienced hyperglycemia and decreased insulin secretion (29).  
2.2.2 Vaginal Microbiota 
There is also evidence of changes in the vaginal microb ota composition in mice during 
pregnancy. Diversity of the bacterial community actu lly increased during early gestation and 
then decreased early postpartum (31), a finding disparate with human studies (see 2.1.2). In 
addition, the gut microbiota of the offspring resembled the maternal vaginal microbiota in early 
postnatal life and at weaning it more resembled that of the maternal gut microbiota (31).   















To our knowledge there are currently no investigations into the interactions between host 
genetics and the microbiome during pregnancy or in ffspring during early postnatal 
development in preclinical models. There is conflicting evidence regarding the role of host 
genetics in human and mouse gut microbiota colonization nd composition (32-34).  
4.0 Prenatal Environment and the Microbiota 
Although it is commonly thought that initial gut colonization occurs at birth during vaginal 
delivery, there is some albeit controversial evidence of a prenatal microbiome (35, 36). Bacteria 
have been isolated from human meconium, stool that forms in the fetus before birth, and others 
have found morphological and sequencing evidence of a placental microbiome resembling the 
oral microbiome (37-40). Although a placental microbiome may not necessarily be transferred to 
the fetus in utero, it may be involved in fetal development. However, placental colonization 
might occur during labor due to ruptures in the placental barrier (35). Although bacteria have 
been isolated from the umbilical cord of infants born by umbilical Caesarean section (41) many 
of these studies have been criticized due to a lack of proper controls for contamination, evidence 
of viable bacteria rather than finding evidence of bacterial genes through sequencing, or 
inappropriate molecular approaches to detect the bacteri  (36). The existence of germ-free mouse 
models is also further evidence against the prenatal microbiome (36).  However, it is clear that a 
number of factors can influence the maternal microbiome in pregnancy that can either directly or 
indirectly affect the developing fetal brain. 
4.1 Drugs and the Microbiota 
Over a quarter of pharmaceutical drugs have been shown to impact the composition of the 















drugs (46). See Table 1 for more details on the impact of prescription drugs on the microbiota 
and behavior of offspring. However, there are few studies investigating the prenatal effect of 
drugs on the microbiota. 
4.1.1 Antibiotics 
Antibiotics are the most commonly prescribed drug dring pregnancy (47), and reduce the 
diversity and bacterial load of the microbiome through bactericidal or bacteriostatic actions.  
Succinyl sulfa thiazole administration during pregnancy in rats caused sex-specific impairments 
social behavior of the offspring as well as impairments in pre-pulse inhibition – an 
endophenotype of schizophrenia (43). A combination of on-absorbable antibiotics, administered 
to mice during pregnancy, reduced exploratory behavior in their offspring (48). This is further 
validated by germ-free mouse models, which display social impairments as well as abnormal 
microglial development (12, 49, 50). Microglia have recently been shown to play an important 
role in neurodevelopment (51). Accordingly, sex-specific aspects of microglial activation which 
persisted in adulthood in germ-free mice may contribu e to the sex biases in psychiatric disorders 
in later life (50).  
4.1.2 Antidepressants 
Different classes of antidepressant drugs including tricyclic antidepressants (52) and selective 
serotonin inhibitors (53), as well as ketamine (54) which may be used in the future as a new 
treatment, impact the growth of bacteria. It is unclear if their bacteriocidal/bacteriostatic actions 
impact their efficacy. Prenatal exposure to selectiv  serotonin reuptake inhibitors induces 
anxiety-like and depressive-like behavior in adulthood (55) in rodents, though the implications of 















drugs  may impact birth weight and motor development in humans, as well as in animal models 
(57); however  potential mechanisms are unknown. Due to the prevalence of antidepressant 
administration during pregnancy (58), it is crucial to characterize the interaction between 
maternal mental health, antidepressant administration and the offspring’s microbiota and mental 
health. 
4.1.3 Drugs of Abuse 
The impact of several substances of abuse on the microbiome have not yet been conducted. In 
rodents, ethanol (59-61) and cocaine exposure (62) have shown effects on the gut microbiota 
composition. In humans, alcohol exposure during prenancy leads to the development of fetal 
alcohol spectrum disorders (63). The severity of these effects on the brain may however 
supersede its impact from changes in the maternal microbiota.  Future studies should identify if 
different gut microbiota compositions are more susceptible to the effects of these substances 
during pregnancy, as well as their impacts on the newborn. 
4.1.4 Valproate/Valproic Acid 
Valproate is an anti-epileptic and mood stabilizer but is also a known teratogen; exposure during 
gestation results in a 4% risk in autism-spectrum disor er (64) and has been able to produce 
autistic endophenotypes in prenatally exposed rodents (44, 65, 66). Valproic acid increased the 
Firmicutes/Bacteroidetes ratio and altered caecal butyrate in the gut microbiota of the male 
offspring (44). However, these changes likely involves its activity as a histone deacetylase 
inhibitor (67) rather than its anti-epileptic mechanism (see which may involve voltage-dependent 
sodium channels and the gamma-aminobutyric acid system (68)). Other pharmaceutical drugs 















4.2 Maternal Diet and the Microbiome 
4.2.1 Unhealthy diet 
Unhealthy diet in humans leads to obesity and poor cardiovascular health but recent research has 
also shown its impact on neurocognitive development in both humans and rodents (69). Common 
rodent models of unhealthy diet include high-fat diet (36-60 % kcal from fat), Western diet (high 
fat and high sugar) as well as diets focusing on specific types of fats. Some of these studies have 
been criticized because improper controls are often selected and may introduce confounds that 
complicate the interpretation of admittedly intriguing results (70, 71). A maternal high-fat diet in 
mice resulted in higher-fold increases in abundance of bacteria in the gut microbiome of the 
mother during pregnancy, and differences in compositional changes compared to animals fed a 
control diet (30). In addition, both prenatal and adolescent exposure to a high fat diet changed the 
gut metabolome and microbiota composition in mouse, rat and macaques (30, 72-74). Prenatal 
Western diet has also been shown to alter the gut microbiota composition leading to an increased 
Firmicutes/Bacteroidetes ratio as well as sex-specific differences in colonic gene expression (75). 
Although the impact of prenatal trans-fatty acid exposure on the microbiota has not been 
determined, it can alter hypothalamic function of prenatally exposed rodents in adulthood (76). 
Furthermore, unhealthy diets during pregnancy in mice also lead to sex-specific differences in 
gene expression (77, 78), social deficits (73, 78),altered hypothalamic stress response (79) and 
inflammation (79, 80) in the offspring (see Table 2). This suggests that a greater emphasis should 
be placed on nutrition during pregnancy, though it is unclear if these changes in maternal 
microbiota directly impact the stress response in human infants. 















Several nutrients may play a positive role in neurodevelopment and microbiota maturation. A 
high-fat diet supplemented with omega-3 polyunsaturated fatty acids increased the diversity of 
microbiota and enriched Bifidobacterium at a species level (81). Omega-3 intake during 
pregnancy regulated the hypothalamic-pituitary-adrenal (HPA) axis activity, shifted the maternal 
stress-induced gut microbiota composition to be more similar to an unstressed composition and 
conferred resilience to stress later in life; in cotrast, a deficit in omega-3 polyunsaturated fatty 
acids affected the metabolome, impaired communication and social behavior, while increasing 
depressive-like behavior (82-85).  
 
4.2.3 Prebiotics 
Prebiotics promote the growth of beneficial bacteria and include indigestible fibers that are 
fermented by colonic bacteria to produce short-chain fatty acids and provide a health benefit, 
though their effects on neurodevelopment have not been well studied (86). Administration of the 
prebiotics galactooligosaccharide and inulin in mice reduced immune activation and intestinal 
permeability in offspring through gut microbiota modulation (87). The prenatal administration of 
caprine milk oligosaccharide in mice has been shown to i crease Bifidobacteria and butyric acid 
in the offspring colon (88). Interestingly, the addition of inulin to a mouse maternal high-fat diet 
abrogated the negative metabolic effects of the high-fat diet on offspring (89).  
4.2.4 Probiotics 
Probiotics are beneficial strains of bacteria that confer a health benefit to the host. 
Administration during pregnancy in humans can reduc the risk of atopy but not other immunity-















effectiveness (92) . Although there is a lack of research on the prenatal impact of probiotics 
within our current scope, several studies have investigated the effects of postnatal administration 
of probiotics for improving psychiatric symptoms (i.e. anxiety or autism-spectrum disorder-like; 
see 6.2.4). It is evident that more animal and human research must be conducted to determine the 
impact of prenatal probiotics on the maternal and offspring microbiota.  
4.3 Maternal Stress 
Maternal stress is modulated by the HPA axis and has been shown to impact this axis in the 
offspring. In offspring, maternal stress has increased serum levels of corticosterone, increased 
anxiety, social impairment and altered the resilience of different strains of rodents (93-97). 
Maternal stress can also alter the gut and vaginal microbiota during pregnancy, decreasing 
diversity of maternal gut microbiota as well as dysregulating glucose metabolism in mice (31). 
Varied prenatal stress interrupted normal pregnancy-related compositional changes in the mouse 
vaginal microbiota and also altered the protein content in the vaginal mucosa, which may have 
contributed to altered abundance of Firmicutes and Bacteroidetes in their offspring’s gut 
microbiota (98). After pregnant mice experienced restraint stress specifically, female offspring 
showed more anxiety-like behaviors as well as decreases in brain-derived neurotrophic factor in 
the placenta concurrent with later decreases of its expression in the adult amygdala (99).   
In humans, ongoing maternal stress (inclusive of prenatal and postnatal stress) has been 
associated with mental health problems in adult offspring (100), as well as with influencing the 
development of the offspring microbiota over the first 110 days after birth (101).  However, the 
mechanism by which the negative impact of maternal stress is transmitted to the offspring’s 















4.4 Maternal Immune Activation 
The maternal immune activation model is based around the controversial idea that maternal 
infections during pregnancy can impact psychiatric outcomes in the children (103). A rodent 
model of maternal immune activation commonly administers viral mimetic poly(I:C) or bacterial 
lipopolysaccharide to produce psychiatric endophenotypes in offspring. Specifically, the viral 
mimetic poly(I:C) administered at E12.5 in mice altered the gut microbiota composition and 
increased gut leakiness by decreasing claudin expression, while also elevating intestinal cytokine 
levels, including interleukin-6 in offspring (104). This model also elevated the bacterial 
production of, 4-ethylphenylsulfate, which induced anxiety-like symptoms in wild-type mice 
(104).  However, there is heterogeneity in the time of administration of the viral mimetic 
poly(I:C) which can lead to the development of different biomarkers or behaviors common to 
different disorders including schizophrenia (105, 106) or autism-spectrum disorder-like 
behaviors in mice (107), and inconsistent depression-like endophenotypes in rats and mice (108).  
Though there exists no current research of its impact on the microbiota, the bacterial mimetic 
lipopolysaccharide can also induce behavioral phenotypes for anxiety, depression, or autism 
spectrum disorder in offspring (109, 110); impairments in hippocampal development and 
neurogenesis (111, 112); and increased postnatal inflammation (110). In mice, 
lipopolysaccharide-induced maternal inflammation caused placental damage and fetal intestinal 
injuries that persisted in adulthood (113); further studies should focus on the potential of a 
placental microbiome to mediate these interactions. 















There are now a large number of studies showing a marked effect of mode of delivery on the gut 
microbiome (20, 27, 114-126), although some studies have found less of an influence than others 
(127).  Infants born via Caesarean-section (C-section) had a gut microbiota more similar to the 
maternal skin microbiota than the vagina (20, 27, 114, 115), delayed Bacteroides colonization 
(114, 115), delayed Lactobacillus colonization (27),  lower circulating chemokines (20) and a 
higher risk of vertical obesity transmission from their mother (126). Similar to humans, C-
section mice initially had a significantly different gut microbiota from their mother (128). In 
addition, they had significant differences in the abundance of bacteria in the orders Clostrodiales 
and Bacteroidales as well as lower systemic interleukin-10 expression (128). Although the 
restoration of the microbiota in Caesarean born infants using a vaginal swab has been piloted, the 
long term consequences of such an intervention haveyet to be studied (129). Alterations in the 
microbiota induced by C-section may play a functional role in predisposing such infants to a 
greater relative risk of allergy, asthma, obesity and Type 1 Diabetes (126, 130, 131). The relative 
contribution of such disturbances to brain health is less clear although epidemiology and animal 
studies are beginning to unlock some clear links (132- 36). 
6.0 Postnatal Environment and the Microbiota 
6.1 Postnatal Drugs and the Microbiota 
Few studies have assessed the impact of postnatal drugs on the microbiota and behavior (see 
Table 1); this section summarizes the existing literature. 
6.1.1 Antibiotics 
Exposure to antibiotics within the first three years of life in humans decreased microbiome 















(137) and increased adiposity in males during childhood (138). Moreover, neonatal exposure in 
rodents to antibiotics have been shown to alter the microbiota, brain inflammation and behavior 
(139), contribute to obesity (140), increase visceral pain receptors and sensitivity (141) . More 
research must be conducted to elucidate the effects of ommon prescriptions of early-life 
antibiotics on brain-health in later life. 
6.1.2 Antidepressants 
In humans, antidepressants have been shown to transfe  through breast milk and some can reach 
a clinically significant concentration in the infant’s serum (142), though their effects on the 
infant have not yet been established (143). In rodents, early postnatal exposure to selective 
serotonin inhibitors alters their social behavior, anxiety-like and depressive-like behaviors (144, 
145).  There are no studies investigating the impact of early exposure of these drugs to the gut 
microbiota composition.  
6.1.3 Antipsychotics 
Similarly, the effects of antipsychotics during breastfeeding – and whether they are able to 
transfer to the infant in a clinically significant concentration are currently unknown. However, 
antipsychotics have been shown to impact the microbiota in rats and adolescent children, leading 
to weight gain (45, 146, 147). It is unclear if similar effects on the microbiota occur as a result of 
antipsychotic transfer through breast milk, and if this interaction impacts infant 
neurodevelopment.  
6.2 Postnatal Diet and the Microbiota 
The stability and composition of the early postnatal gut microbiota community is strongly 















infants (148). There are now more studies examining the impact of both healthy and unhealthy 
diets in early life. 
6.2.1 Unhealthy Diet 
An unhealthy diet commencing in early postnatal life also alters the microbiota composition 
(149) and results in different behavioral and inflammatory phenotypes (see Table 2). High-fat 
diet after weaning and during adolescence altered th  HPA-axis in female rats and impaired 
hippocampal memory and increased hippocampal lipopolysaccharide-induced cytokine response 
in the males (150, 151). Meanwhile high-fat diet bingeing during adolescence in mice increased 
anxiety and cocaine self-administration in adulthood (152).  
6.2.2 Prebiotics 
Few published studies have assessed the impact of early life prebiotics administration in humans 
on psychiatric outcomes but have shown effects in reducing the risk of atopy, an autoimmune 
disease (153). In juvenile rats, inulin administered for two weeks increased basal corticosterone 
levels and elevated corticosterone after an anxiety-inducing stimulus, but the animals showed 
less anxiety in behavioral tests (154).  
6.2.3 Probiotics 
In humans, probiotics may reduce the risk of depression (155) and autism (156, 157). In rodents, 
Lactobacillus administration had similar effects to inulin, reducing anxiety through the HPA axis 
(154). Interestingly, when combined with inulin, it d d not affect the corticosterone levels and 
increased 5-HT1A receptor mRNA in the hippocampus, a receptor associated with anxiety and 
depression (154). Notably, Lactobacillus rhamnosus and L. helveticus administration in stressed 















relapse after extinction in early life (158). Some strains, such as Bifidobacteria longum and 
Bifidobacteria breve, can mediate anti-anxiety and anti-depressive behaviors in preclinical 
rodent models (159). In mice, Bifidobacterium breve combined with prebiotics in early life 
exerted protection from the negative metabolic effects of a Western diet (160), showing promise 
for co-administration of prebiotics and probiotics.  
6.3 Postnatal Stress and the Microbiota 
Early postnatal stress impacts the HPA-axis and contributes to the programming of brain health 
in later life (161). Different types of early postna al stress (social isolation, maternal separation) 
alter the gut microbiota composition and metabolism in rats (162-164) and their inflammatory 
profiles (163, 164). Social isolation also impaired memory and learning in rats (163).  Finally, 
germ free mice were more vulnerable to restraint stres  – resulting in higher adrenocorticotropic 
hormone and corticosterone in plasma (165, 166), a reduction in glucocorticoid receptor mRNA 
and an increased stress response (165). Remarkably, these effects were rescued with microbiota 
transplantation during adolescence but not adulthood (165).  
7.0 Sex-Specific Programming of Psychiatric Disorders Later in Life 
Many psychiatric disorders differ among the sexes in terms of prevalence or onset – including 
autism (167), mood disorders (168), anxiety disorders (168) and schizophrenia (169). The 
underlying biological basis of these sex differences is still unknown. Since microbiota-related 
alterations have shown sex-specific effects after exposure to prenatal or postnatal environmental 
















The gut microbiota and its metabolites influence the development of the microglia, and in its 
absence, development is disrupted in a sex-specific manner (12, 49, 50). Abnormal microglial 
phenotypes were rescued with short-chain fatty acids, produced by certain members of the 
microbiota (12). The microglia are involved in synaptic pruning and maturation during 
neurodevelopment (see review by Salter (170)).   
Other “hits” that disrupt the microbiota could prevent it from reaching a healthy homeostasis 
(171, 172) and result in increased inflammation. In fact, many psychiatric disorders may involve 
the dysregulation of the immune system – including  mood disorders (173-175), schizophrenia 
(176, 177) and autism spectrum disorder (178, 179). Alterations of the microbiota through stress 
and other prenatal or postnatal factors impacted th programming of the HPA axis in a sex-
specific manner (82, 83, 150, 152).  
Since early programming of the HPA-axis and immune system can be affected in a sex-specific 
manner by changes in maternal/offspring microbiota c mposition, a microbiota “hit” could 
program health and disease later in life.  
8.0 Conclusion 
Several decades after Barker first proposed the role of prenatal factors on health and disease later 
in life, his ideas have continued to be investigated and expanded upon. The microbiota 
community transmitted to the offspring may have plasticity – as other traits described in the 
Barker hypothesis. Dynamic changes in the maternal microbiota and the early offspring 
microbiota would occur due to pre- and postnatal enviro ment respectively, as well as host 
genetics. Although these changes may be beneficial for immediate survival, they may result in 















“hit”, which interacts with the other factors to program for brain health and disease in later life. 
The microbiota is involved in mediating the effects of both postnatal and prenatal diet, drug 
exposure, and stress (see Figure 3). 
This field has potential for the development of new bioactives, and dietary/lifestyle interventions 
that would modulate the microbiota during pregnancy to reduce the risk of disease later in life. 
Moreover, microbiome interventions may also influenc  maternal mental health as recently see 
with a placebo-controlled trial of a Lactobacillus rhamnosus during pregnancy and lactation 
(180).  However, there are few studies directly asses  the impact of changes to the microbiota 
composition in early life on brain health outcomes in adulthood. Further research should focus 
on identifying the interactions between these four “hits” as well as critical periods for microbiota 
modulation to support early neurodevelopment and brain health later in life. As this review 
shows, certain bacteria species are modified in response to developmental stimuli, future work is 
however, needed to understand if there is any convergence to such findings and understand their 























The APC Microbiome Institute is funded by Science Foundation Ireland (SFI), through the Irish 
Government's National Development Plan. JFC TGD CS are supported by SFI (Grant 
12/RC/2273). We would also like to acknowledge Dr. Caitlin S. Cowan for advice with figure 
design. 
Financial Disclosures 
The APC Microbiome Institute has conducted research funded by many Pharmaceutical and 
Food Companies. MGC, SS, SOM, OFOL and CS have no co flicts of interest to declare. GC 
has been invited to a meeting organized by Janssen. TGD has been an invited speaker at 
meetings organized by Servier, Lundbeck, Janssen, and AstraZeneca and has received research 
funding from Mead Johnson, Cremo, Suntory Wellness, Nutricia, and 4D Pharma. JFC has been 
an invited speaker at meetings organized by Mead Johnson, Yakult, Alkermes and Janssen and 
has received research funding from Mead Johnson, Cremo, Suntory Wellness, Nutricia, Dupont, 
















1. Barker DJ (1990): The fetal and infant origins of adult disease. BMJ (Clinical research ed). 
301:1111. 
2. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ (1989): Weight in infancy and death 
from ischaemic heart disease. Lancet. 2:577-580. 
3. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993): Fetal nutrition 
and cardiovascular disease in adult life. Lancet. 341:938-941. 
4. Barker DJ (2004): The developmental origins of adult disease. J Am Coll Nutr. 23:588S-595S. 
5. Lederberg J, McCray AT (2001): 'Ome Sweet 'Omics -- A Generalogical Treasury of Words. The 
Scientist. 
6. Dave M, Higgins PD, Middha S, Rioux KP (2012): The human gut microbiome: current knowledge, 
challenges, and future directions. Transl Res. 160:246-257. 
7. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. (2009): The NIH Human 
Microbiome Project. Genome Res. 19:2317-2323. 
8. Funkhouser LJ, Bordenstein SR (2013): Mom knows best: the universality of maternal microbial 
transmission. PLoS Biol. 11:e1001631. 
9. Enos MK, Burton JP, Dols J, Buhulata S, Changalucha J, Reid G (2013): Probiotics and nutrients 
for the first 1000 days of life in the developing world. Benef Microbes. 4:3-16. 
10. Sender R, Fuchs S, Milo R (2016): Revised Estimates for the Number of Human and Bacteria Cells 
in the Body. PLoS Biol. 14:e1002533. 
11. de Weerth C (2017): Do bacteria shape our development? Crosstalk between intestinal 
microbiota and HPA axis. Neurosci Biobehav Rev. 83:458-471. 
12. Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. (2015): Host 
microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 18:965-
977. 
13. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. (2011): Ingestion of 
Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via 
the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America. 
108:16050-16055. 
14. König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, et al. (2016): Human 
Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol. 7:e196. 
15. Dinan TG, Cryan JF (2012): Regulation of the stress response by the gut microbiota: implications 
for psychoneuroendocrinology. Psychoneuroendocrinology. 37:1369-1378. 
16. Priyadarshini M, Thomas A, Reisetter AC, Scholtens DM, Wolever TM, Josefson JL, et al. (2014): 
Maternal short-chain fatty acids are associated with metabolic parameters in mothers and newborns. 
Transl Res. 164:153-157. 
17. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. (2012): Host 
remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 150:470-480. 
18. Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, et al. (2010): Gut 
microbiota composition is associated with body weight, weight gain and biochemical parameters in 
pregnant women. Br J Nutr. 104:83-92. 
19. Collado MC, Isolauri E, Laitinen K, Salminen S (2008): Distinct composition of gut microbiota 
during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 88:894-899. 
20. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, et al. (2014): 
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in 















21. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, et al. (2007): Comparative 
metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14:169-181. 
22. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. (2014): The composition and 
stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant 
women. Microbiome. 2:4. 
23. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. (2011): Vaginal microbiome 
of reproductive-age women. Proceedings of the National Academy of Sciences of the United States of 
America. 108 Suppl 1:4680-4687. 
24. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, et al. (2015): 
Temporal and spatial variation of the human microbiota during pregnancy. Proceedings of the National 
Academy of Sciences of the United States of America. 112:11060-11065. 
25. MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, et al. (2015): The 
vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep. 
5:8988. 
26. Aagaard K, Riehle K, Ma J, Segata N, Mistretta TA, Coarfa C, et al. (2012): A metagenomic 
approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One. 7:e36466. 
27. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. (2010): 
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body 
habitats in newborns. Proceedings of the National Academy of Sciences of the United States of America. 
107:11971-11975. 
28. Ley RE, Peterson DA, Gordon JI (2006): Ecological and evolutionary forces shaping microbial 
diversity in the human intestine. Cell. 124:837-848. 
29. Fuller M, Priyadarshini M, Gibbons SM, Angueira AR, Brodsky M, Hayes MG, et al. (2015): The 
short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis. Am J Physiol 
Endocrinol Metab. 309:E840-851. 
30. Gohir W, Whelan FJ, Surette MG, Moore C, Schertzer JD, Sloboda DM (2015): Pregnancy-related 
changes in the maternal gut microbiota are dependent upon the mother's periconceptional diet. Gut 
Microbes. 6:310-320. 
31. Jašarević E, Howard CD, Misic AM, Beiting DP, Bale TL (2017): Stress during pregnancy alters 
temporal and spatial dynamics of the maternal and offspring microbiome in a sex-specific manner. Sci 
Rep. 7:44182. 
32. Goodrich JK, Davenport ER, Clark AG, Ley RE (2017): The Relationship Between the Human 
Genome and Microbiome Comes into View. Annu Rev Genet. 51:413-433. 
33. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. (2018): Environment 
dominates over host genetics in shaping human gut microbiota. Nature. 
34. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. (2012): Gut immune 
maturation depends on colonization with a host-specific microbiota. Cell. 149:1578-1593. 
35. Willyard C (2018): Could baby's first bacteria take root before birth? Nature. 553:264-266. 
36. Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, Walter J (2017): A critical assessment of the 
"sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant 
microbiome. Microbiome. 5:48. 
37. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. (2008): Is meconium from 
healthy newborns actually sterile? Res Microbiol. 159:187-193. 
38. Ardissone AN, de la Cruz DM, Davis-Richardson AG, Rechcigl KT, Li N, Drew JC, et al. (2014): 
Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One. 9:e90784. 
39. Stout MJ, Conlon B, Landeau M, Lee I, Bower C, Zhao Q, et al. (2013): Identification of 
intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J 















40. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J (2014): The placenta harbors a 
unique microbiome. Science translational medicine. 6:237ra265. 
41. Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, et al. (2005): 
Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean 
section. Curr Microbiol. 51:270-274. 
42. Le Bastard Q, Al-Ghalith GA, Grégoire M, Chapelet G, Javaudin F, Dailly E, et al. (2018): 
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment 
Pharmacol Ther. 47:332-345. 
43. Degroote S, Hunting DJ, Baccarelli AA, Takser L (2016): Maternal gut and fetal brain connection: 
Increased anxiety and reduced social interactions in Wistar rat offspring following peri-conceptional 
antibiotic exposure. Prog Neuropsychopharmacol Biol Psychiatry. 71:76-82. 
44. de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, et al. (2014): 
Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav 
Immun. 37:197-206. 
45. Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF, et al. (2013): Antipsychotics and 
the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic 
administration in the rat. Transl Psychiatry. 3:e309. 
46. Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. (2018): Extensive impact 
of non-antibiotic drugs on human gut bacteria. Nature. 555:623-628. 
47. Kuperman AA, Koren O (2016): Antibiotic use during pregnancy: how bad is it? BMC Med. 14:91. 
48. Tochitani S, Ikeno T, Ito T, Sakurai A, Yamauchi T, Matsuzaki H (2016): Administration of Non-
Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with 
Alterations in Offspring Behavior. PLoS One. 11:e0138293. 
49. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF (2014): Microbiota is essential for social 
development in the mouse. Mol Psychiatry. 19:146-148. 
50. Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte-Schrepping J, et al. (2018): Microbiome 
Influences Prenatal and Adult Microglia in a Sex-Specific Manner. Cell. 172:500-516.e516. 
51. Bilimoria PM, Stevens B (2015): Microglia function during brain development: New insights from 
animal models. Brain Res. 1617:7-17. 
52. Csiszar K, Molnar J (1992): Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia 
enterocolitica plasmid maintenance and replication. Anticancer Res. 12:2267-2272. 
53. Munoz-Bellido JL, Munoz-Criado S, Garcìa-Rodrìguez JA (2000): Antimicrobial activity of 
psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents. 14:177-180. 
54. Yang C, Qu Y, Fujita Y, Ren Q, Ma M, Dong C, et al. (2017): Possible role of the gut microbiota-
brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. Transl Psychiatry. 
7:1294. 
55. Homberg JR, Schubert D, Gaspar P (2010): New perspectives on the neurodevelopmental effects 
of SSRIs. Trends Pharmacol Sci. 31:60-65. 
56. Gur TL, Kim DR, Epperson CN (2013): Central nervous system effects of prenatal selective 
serotonin reuptake inhibitors: sensing the signal through the noise. Psychopharmacology (Berl). 
227:567-582. 
57. Hutchison SM, Mâsse LC, Pawluski JL, Oberlander TF (2018): Perinatal selective serotonin 
reuptake inhibitor (SSRI) effects on body weight at birth and beyond: A review of animal and human 
studies. Reprod Toxicol. 77:109-121. 
58. Koren G, Nordeng H (2012): Antidepressant use during pregnancy: the benefit-risk ratio. Am J 
Obstet Gynecol. 207:157-163. 
59. Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E, et al. (2011): Enteric dysbiosis 















60. Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M, Gillevet P (2009): Intestinal 
dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. 
Alcohol Clin Exp Res. 33:1836-1846. 
61. Peterson VL, Jury NJ, Cabrera-Rubio R, Draper LA, Crispie F, Cotter PD, et al. (2017): Drunk bugs: 
Chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice. Behav Brain 
Res. 323:172-176. 
62. Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, et al. (2016): Alterations of the 
Host Microbiome Affect Behavioral Responses to Cocaine. Sci Rep. 6:35455. 
63. Sokol RJ, Delaney-Black V, Nordstrom B (2003): Fetal alcohol spectrum disorder. JAMA. 
290:2996-2999. 
64. Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, et al. (2013): 
Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 
309:1696-1703. 
65. Schneider T, Przewłocki R (2005): Behavioral alterations in rats prenatally exposed to valproic 
acid: animal model of autism. Neuropsychopharmacology. 30:80-89. 
66. Codagnone MG, Podestá MF, Uccelli NA, Reinés A (2015): Differential Local Connectivity and 
Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat 
Model of Autism. Dev Neurosci. 37:215-231. 
67. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001): Histone deacetylase is a 
direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 
276:36734-36741. 
68. Löscher W (1999): Valproate: a reappraisal of its pharmacodynamic properties and mechanisms 
of action. Prog Neurobiol. 58:31-59. 
69. Monk C, Georgieff MK, Osterholm EA (2013): Research review: maternal prenatal distress and 
poor nutrition - mutually influencing risk factors affecting infant neurocognitive development. J Child 
Psychol Psychiatry. 54:115-130. 
70. Almeida-Suhett CP, Scott JM, Graham A, Chen Y, Deuster PA (2017): Control diet in a high-fat 
diet study in mice: Regular chow and purified low-fat diet have similar effects on phenotypic, metabolic, 
and behavioral outcomes. Nutr Neurosci.1-10. 
71. Pellizzon MA, Ricci MR (2018): The common use of improper control diets in diet-induced 
metabolic disease research confounds data interpretation: the fiber factor. Nutr Metab (Lond). 15:3. 
72. Oberbach A, Haange SB, Schlichting N, Heinrich M, Lehmann S, Till H, et al. (2017): Metabolic in 
Vivo Labeling Highlights Differences of Metabolically Active Microbes from the Mucosal Gastrointestinal 
Microbiome between High-Fat and Normal Chow Diet. J Proteome Res. 16:1593-1604. 
73. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M (2016): 
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell. 
165:1762-1775. 
74. Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K, et al. (2014): High-fat maternal diet during 
pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun. 5:3889. 
75. Steegenga WT, Mischke M, Lute C, Boekschoten MV, Lendvai A, Pruis MG, et al. (2017): 
Maternal exposure to a Western-style diet causes differences in intestinal microbiota composition and 
gene expression of suckling mouse pups. Mol Nutr Food Res. 61. 
76. Pimentel GD, Lira FS, Rosa JC, Oliveira JL, Losinskas-Hachul AC, Souza GI, et al. (2012): Intake of 
trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFκBp65 
signaling in adult offspring. J Nutr Biochem. 23:265-271. 
77. Edlow AG, Guedj F, Pennings JL, Sverdlov D, Neri C, Bianchi DW (2016): Males are from Mars, 
and females are from Venus: sex-specific fetal brain gene expression signatures in a mouse model of 















78. Graf AE, Lallier SW, Waidyaratne G, Thompson MD, Tipple TE, Hester ME, et al. (2016): Maternal 
high fat diet exposure is associated with increased hepcidin levels, decreased myelination, and 
neurobehavioral changes in male offspring. Brain Behav Immun. 58:369-378. 
79. Grissom NM, George R, Reyes TM (2017): The hypothalamic transcriptional response to stress is 
severely impaired in offspring exposed to adverse nutrition during gestation. Neuroscience. 342:200-
211. 
80. Du Y, Yang M, Lee S, Behrendt CL, Hooper LV, Saghatelian A, et al. (2012): Maternal western diet 
causes inflammatory milk and TLR2/4-dependent neonatal toxicity. Genes Dev. 26:1306-1311. 
81. Patterson E, O' Doherty RM, Murphy EF, Wall R, O' Sullivan O, Nilaweera K, et al. (2014): Impact 
of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. 
Br J Nutr. 111:1905-1917. 
82. Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. (2017): Omega-
3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in 
adolescence and adulthood. Brain Behav Immun. 59:21-37. 
83. Weiser MJ, Wynalda K, Salem N, Butt CM (2015): Dietary DHA during development affects 
depression-like behaviors and biomarkers that emerge after puberty in adolescent rats. J Lipid Res. 
56:151-166. 
84. Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. (2017): 
Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice. Br J 
Nutr. 118:959-970. 
85. Pusceddu MM, El Aidy S, Crispie F, O'Sullivan O, Cotter P, Stanton C, et al. (2015): N-3 
Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota. PLoS 
One. 10:e0139721. 
86. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. (2017): Expert 
consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) 
consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 14:491-
502. 
87. Bouchaud G, Castan L, Chesné J, Braza F, Aubert P, Neunlist M, et al. (2016): Maternal exposure 
to GOS/inulin mixture prevents food allergies and promotes tolerance in offspring in mice. Allergy. 
71:68-76. 
88. Thum C, McNabb WC, Young W, Cookson AL, Roy NC (2016): Prenatal caprine milk 
oligosaccharide consumption affects the development of mice offspring. Mol Nutr Food Res. 60:2076-
2085. 
89. Zou J, Chassaing B, Singh V, Pellizzon M, Ricci M, Fythe MD, et al. (2018): Fiber-Mediated 
Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated 
Colonic Health. Cell Host Microbe. 23:41-53.e44. 
90. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E (2013): Probiotic administration in 
early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 132:e666-676. 
91. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, et al. (2013): Probiotic 
supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic 
review and meta-analysis. BMJ (Clinical research ed). 347:f6471. 
92. Reid G, Kirjaivanen P (2005): Taking probiotics during pregnancy. Are they useful therapy for 
mothers and newborns? Can Fam Physician. 51:1477-1479. 
93. Lee YA, Kim YJ, Goto Y (2016): Cognitive and affective alterations by prenatal and postnatal 
stress interaction. Physiol Behav. 165:146-153. 
94. Rana S, Pugh PC, Jackson N, Clinton SM, Kerman IA (2015): Inborn stress reactivity shapes adult 















95. Bale TL (2015): Epigenetic and transgenerational reprogramming of brain development. Nat Rev 
Neurosci. 16:332-344. 
96. Hiroi R, Carbone DL, Zuloaga DG, Bimonte-Nelson HA, Handa RJ (2016): Sex-dependent 
programming effects of prenatal glucocorticoid treatment on the developing serotonin system and 
stress-related behaviors in adulthood. Neuroscience. 320:43-56. 
97. Golubeva AV, Crampton S, Desbonnet L, Edge D, O'Sullivan O, Lomasney KW, et al. (2015): 
Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota 
composition in adulthood. Psychoneuroendocrinology. 60:58-74. 
98. Jašarević E, Howerton CL, Howard CD, Bale TL (2015): Alterations in the Vaginal Microbiome by 
Maternal Stress Are Associated With Metabolic Reprogramming of the Offspring Gut and Brain. 
Endocrinology. 156:3265-3276. 
99. Gur TL, Shay L, Palkar AV, Fisher S, Varaljay VA, Dowd S, et al. (2017): Prenatal stress affects 
placental cytokines and neurotrophins, commensal microbes, and anxiety-like behavior in adult female 
offspring. Brain Behav Immun. 64:50-58. 
100. Betts KS, Williams GM, Najman JM, Alati R (2015): The relationship between maternal 
depressive, anxious, and stress symptoms during pregnancy and adult offspring behavioral and 
emotional problems. Depress Anxiety. 32:82-90. 
101. Zijlmans MA, Korpela K, Riksen-Walraven JM, de Vos WM, de Weerth C (2015): Maternal 
prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology. 53:233-
245. 
102. Kang LJ, Koleva PT, Field CJ, Giesbrecht GF, Wine E, Becker AB, et al. (2018): Maternal depressive 
symptoms linked to reduced fecal Immunoglobulin A concentrations in infants. Brain Behav Immun. 
68:123-131. 
103. Estes ML, McAllister AK (2016): Maternal immune activation: Implications for neuropsychiatric 
disorders. Science. 353:772-777. 
104. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. (2013): Microbiota modulate 
behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 
155:1451-1463. 
105. Juckel G, Manitz MP, Brüne M, Friebe A, Heneka MT, Wolf RJ (2011): Microglial activation in a 
neuroinflammational animal model of schizophrenia--a pilot study. Schizophr Res. 131:96-100. 
106. Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U, et al. (2009): Prenatal immune challenge is an 
environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in 
a mouse model. PLoS One. 4:e6354. 
107. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH (2012): Maternal immune activation 
yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun. 
26:607-616. 
108. Ronovsky M, Berger S, Molz B, Berger A, Pollak DD (2016): Animal Models of Maternal Immune 
Activation in Depression Research. Curr Neuropharmacol. 14:688-704. 
109. Depino AM (2015): Early prenatal exposure to LPS results in anxiety- and depression-related 
behaviors in adulthood. Neuroscience. 299:56-65. 
110. Oskvig DB, Elkahloun AG, Johnson KR, Phillips TM, Herkenham M (2012): Maternal immune 
activation by LPS selectively alters specific gene expression profiles of interneuron migration and 
oxidative stress in the fetus without triggering a fetal immune response. Brain Behav Immun. 26:623-
634. 
111. Escobar M, Crouzin N, Cavalier M, Quentin J, Roussel J, Lanté F, et al. (2011): Early, time-
dependent disturbances of hippocampal synaptic transmission and plasticity after in utero immune 















112. Romero E, Ali C, Molina-Holgado E, Castellano B, Guaza C, Borrell J (2007): Neurobehavioral and 
immunological consequences of prenatal immune activation in rats. Influence of antipsychotics. 
Neuropsychopharmacology. 32:1791-1804. 
113. Fricke EM, Elgin TG, Gong H, Reese J, Gibson-Corley KN, Weiss RM, et al. (2018): 
Lipopolysaccharide-induced maternal inflammation induces direct placental injury without alteration in 
placental blood flow and induces a secondary fetal intestinal injury that persists into adulthood. Am J 
Reprod Immunol. 
114. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG (2015): The infant 
microbiome development: mom matters. Trends Mol Med. 21:109-117. 
115. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G (2008): Cesarean delivery may affect the 
early biodiversity of intestinal bacteria. J Nutr. 138:1796S-1800S. 
116. Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. (2015): Dynamics and 
Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 17:690-703. 
117. Madan JC, Hoen AG, Lundgren SN, Farzan SF, Cottingham KL, Morrison HG, et al. (2016): 
Association of Cesarean Delivery and Formula Supplementation With the Intestinal Microbiome of 6-
Week-Old Infants. JAMA Pediatr. 170:212-219. 
118. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C (2010): Mode of delivery affects 
the bacterial community in the newborn gut. Early Hum Dev. 86 Suppl 1:13-15. 
119. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. (2013): Gut microbiota of 
healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 185:385-394. 
120. Salminen S, Gibson GR, McCartney AL, Isolauri E (2004): Influence of mode of delivery on gut 
microbiota composition in seven year old children. Gut. 53:1388-1389. 
121. Brumbaugh DE, Arruda J, Robbins K, Ir D, Santorico SA, Robertson CE, et al. (2016): Mode of 
Delivery Determines Neonatal Pharyngeal Bacterial Composition and Early Intestinal Colonization. J 
Pediatr Gastroenterol Nutr. 63:320-328. 
122. Dogra S, Sakwinska O, Soh SE, Ngom-Bru C, Brück WM, Berger B, et al. (2015): Dynamics of 
infant gut microbiota are influenced by delivery mode and gestational duration and are associated with 
subsequent adiposity. MBio. 6. 
123. Grześkowiak Ł, Sales Teixeira TF, Bigonha SM, Lobo G, Salminen S, Ferreira CL (2015): Gut 
Bifidobacterium microbiota in one-month-old Brazilian newborns. Anaerobe. 35:54-58. 
124. Martin R, Makino H, Cetinyurek Yavuz A, Ben-Amor K, Roelofs M, Ishikawa E, et al. (2016): Early-
Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing 
Gut Microbiota. PLoS One. 11:e0158498. 
125. Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O'Shea CA, et al. (2017): Evolution of gut 
microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome. 5:4. 
126. Tun HM, Bridgman SL, Chari R, Field CJ, Guttman DS, Becker AB, et al. (2018): Roles of Birth 
Mode and Infant Gut Microbiota in Intergenerational Transmission of Overweight and Obesity From 
Mother to Offspring. JAMA Pediatr. 
127. Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM (2017): Maturation of the 
infant microbiome community structure and function across multiple body sites and in relation to mode 
of delivery. Nat Med. 23:314-326. 
128. Hansen CH, Andersen LS, Krych L, Metzdorff SB, Hasselby JP, Skov S, et al. (2014): Mode of 
delivery shapes gut colonization pattern and modulates regulatory immunity in mice. J Immunol. 
193:1213-1222. 
129. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, et al. (2016): 
















130. Bager P, Wohlfahrt J, Westergaard T (2008): Caesarean delivery and risk of atopy and allergic 
disease: meta-analyses. Clin Exp Allergy. 38:634-642. 
131. Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, et al. (2008): Caesarean 
section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis 
of observational studies. Diabetologia. 51:726-735. 
132. O'Neill SM, Curran EA, Dalman C, Kenny LC, Kearney PM, Clarke G, et al. (2016): Birth by 
Caesarean Section and the Risk of Adult Psychosis: A Population-Based Cohort Study. Schizophr Bull. 
42:633-641. 
133. Fond G, Bulzacka E, Boyer L, Llorca PM, Godin O, Brunel L, et al. (2016): Birth by cesarean section 
and schizophrenia: results from the multicenter FACE-SZ data-set. Eur Arch Psychiatry Clin Neurosci. 
134. Moya-Pérez A, Luczynski P, Renes IB, Wang S, Borre Y, Anthony Ryan C, et al. (2017): 
Intervention strategies for cesarean section-induced alterations in the microbiota-gut-brain axis. Nutr 
Rev. 75:225-240. 
135. Martinez KA, Devlin JC, Lacher CR, Yin Y, Cai Y, Wang J, et al. (2017): Increased weight gain by C-
section: Functional significance of the primordial microbiome. Sci Adv. 3:eaao1874. 
136. Curran EA, Kenny LC, Dalman C, Kearney PM, Cryan JF, Dinan TG, et al. (2017): Birth by 
caesarean section and school performance in Swedish adolescents- a population-based study. BMC 
Pregnancy Childbirth. 17:121. 
137. Yassour M, Vatanen T, Siljander H, Hämäläinen AM, Härkönen T, Ryhänen SJ, et al. (2016): 
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain 
diversity and stability. Science translational medicine. 8:343ra381. 
138. Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL (2014): Infant antibiotic exposure and the 
development of childhood overweight and central adiposity. Int J Obes (Lond). 38:1290-1298. 
139. Leclercq S, Mian FM, Stanisz AM, Bindels LB, Cambier E, Ben-Amram H, et al. (2017): Low-dose 
penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. 
Nat Commun. 8:15062. 
140. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, et al. (2012): Antibiotics in early life alter the 
murine colonic microbiome and adiposity. Nature. 488:621-626. 
141. O'Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, et al. (2014): Disturbance 
of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting 
cognitive or anxiety-related behaviors in male rats. Neuroscience. 277:885-901. 
142. Sachs HC, Drugs CO (2013): The transfer of drugs and therapeutics into human breast milk: an 
update on selected topics. Pediatrics. 132:e796-809. 
143. Glover ME, Clinton SM (2016): Of rodents and humans: A comparative review of the 
neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci. 
51:50-72. 
144. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004): Early-life blockade of the 5-HT 
transporter alters emotional behavior in adult mice. Science. 306:879-881. 
145. Rebello TJ, Yu Q, Goodfellow NM, Caffrey Cagliostro MK, Teissier A, Morelli E, et al. (2014): 
Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J Neurosci. 
34:12379-12393. 
146. Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, et al. (2014): The 
antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS One. 
9:e115225. 
147. Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, et al. (2015): Use of the 
second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered 















148. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. (2006): Factors influencing 
the composition of the intestinal microbiota in early infancy. Pediatrics. 118:511-521. 
149. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI (2008): Diet-induced obesity is linked to marked 
but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 3:213-223. 
150. Boukouvalas G, Antoniou K, Papalexi E, Kitraki E (2008): Post weaning high fat feeding affects 
rats' behavior and hypothalamic pituitary adrenal axis at the onset of puberty in a sexually dimorphic 
manner. Neuroscience. 153:373-382. 
151. Boitard C, Cavaroc A, Sauvant J, Aubert A, Castanon N, Layé S, et al. (2014): Impairment of 
hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced 
hippocampal inflammation in rats. Brain Behav Immun. 40:9-17. 
152. Blanco-Gandía MC, Cantacorps L, Aracil-Fernández A, Montagud-Romero S, Aguilar MA, 
Manzanares J, et al. (2017): Effects of bingeing on fat during adolescence on the reinforcing effects of 
cocaine in adult male mice. Neuropharmacology. 113:31-44. 
153. Grüber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP, et al. (2010): Reduced 
occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. 
J Allergy Clin Immunol. 126:791-797. 
154. Barrera-Bugueño C, Realini O, Escobar-Luna J, Sotomayor-Zárate R, Gotteland M, Julio-Pieper M, 
et al. (2017): Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats. 
Neuroscience. 359:18-29. 
155. Huang R, Wang K, Hu J (2016): Effect of Probiotics on Depression: A Systematic Review and 
Meta-Analysis of Randomized Controlled Trials. Nutrients. 8. 
156. Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E (2015): A possible link between early 
probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. 
Pediatr Res. 77:823-828. 
157. Gilbert JA, Krajmalnik-Brown R, Porazinska DL, Weiss SJ, Knight R (2013): Toward effective 
probiotics for autism and other neurodevelopmental disorders. Cell. 155:1446-1448. 
158. Cowan CS, Callaghan BL, Richardson R (2016): The effects of a probiotic formulation 
(Lactobacillus rhamnosus and L. helveticus) on developmental trajectories of emotional learning in 
stressed infant rats. Transl Psychiatry. 6:e823. 
159. Savignac HM, Kiely B, Dinan TG, Cryan JF (2014): Bifidobacteria exert strain-specific effects on 
stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 26:1615-1627. 
160. Mischke M, Arora T, Tims S, Engels E, Sommer N, van Limpt K, et al. (2018): Specific synbiotics in 
early life protect against diet-induced obesity in adult mice. Diabetes Obes Metab. 
161. Heim C, Nemeroff CB (2001): The role of childhood trauma in the neurobiology of mood and 
anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 49:1023-1039. 
162. Farshim P, Walton G, Chakrabarti B, Givens I, Saddy D, Kitchen I, et al. (2016): Maternal Weaning 
Modulates Emotional Behavior and Regulates the Gut-Brain Axis. Sci Rep. 6:21958. 
163. Doherty FD, O'Mahony SM, Peterson VL, O'Sullivan O, Crispie F, Cotter PD, et al. (2018): Post-
weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis. 
Brain Behav Immun. 68:261-273. 
164. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, et al. (2009): Early life 
stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and 
psychiatric illnesses. Biol Psychiatry. 65:263-267. 
165. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. (2004): Postnatal microbial 
colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The 















166. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. (2013): The 
microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-
dependent manner. Mol Psychiatry. 18:666-673. 
167. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C (2003): Prevalence of 
autism in a US metropolitan area. JAMA. 289:49-55. 
168. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. (2010): Lifetime 
prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey 
Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 49:980-989. 
169. Aleman A, Kahn RS, Selten JP (2003): Sex differences in the risk of schizophrenia: evidence from 
meta-analysis. Arch Gen Psychiatry. 60:565-571. 
170. Salter MW, Beggs S (2014): Sublime microglia: expanding roles for the guardians of the CNS. Cell. 
158:15-24. 
171. Kabat AM, Srinivasan N, Maloy KJ (2014): Modulation of immune development and function by 
intestinal microbiota. Trends Immunol. 35:507-517. 
172. Maynard CL, Elson CO, Hatton RD, Weaver CT (2012): Reciprocal interactions of the intestinal 
microbiota and immune system. Nature. 489:231-241. 
173. Capuron L, Miller AH (2011): Immune system to brain signaling: neuropsychopharmacological 
implications. Pharmacol Ther. 130:226-238. 
174. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008): From inflammation to 
sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 9:46-56. 
175. Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, et al. (2012): Can bipolar disorder be 
viewed as a multi-system inflammatory disease? J Affect Disord. 141:1-10. 
176. Laske C, Zank M, Klein R, Stransky E, Batra A, Buchkremer G, et al. (2008): Autoantibody 
reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry 
Res. 158:83-86. 
177. Horváth S, Mirnics K (2014): Immune system disturbances in schizophrenia. Biol Psychiatry. 
75:316-323. 
178. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. (2009): Elevated immune response 
in the brain of autistic patients. J Neuroimmunol. 207:111-116. 
179. Rossignol DA, Frye RE (2012): A review of research trends in physiological abnormalities in 
autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial 
dysfunction and environmental toxicant exposures. Mol Psychiatry. 17:389-401. 
180. Slykerman RF, Hood F, Wickens K, Thompson JMD, Barthow C, Murphy R, et al. (2017): Effect of 
Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A 















Table 1. Prenatal and postnatal impact of drugs. This table summarizes the prenatal and postnatal impact of drugs on the microbiota, 





Effect  Reference 
Proton Pump Inhibitors Humans Postnatal ↑ incidence of C. difficile and other infections 
Change in gut microbiota composition and 
diversity 
↑ in Bacteroidales order, Streptococcus genus 
↓ Firmicutes  
(42) 
Metformin Humans Postnatal Changes in gut microbiota composition and 




Humans Postnatal Distinct changes in microbiota composition 
allowing for prediction of changes to different 
types of drugs involved in overlapping intestinal 
development pathways 
(42) 
Opioids Humans Postnatal ↑ in alpha diversity, association with 
compositional distance 
↑ Peptostreptococcaceae, ↓ Parasutterella 




Humans Postnatal Association with beta diversity 




Humans Postnatal ↓ alpha diversity, altered beta diversity 








↑ Gut microbiota diversity 
↑ Weight gain associated with Clostridium sp., 
Lactobacillus sp., Ralstonia sp. And 




Female Rats Postnatal ↑ Firmicutes to Bacteroidetes ratio, body weight 


















Mice Postnatal ↑ Body weight  
Effects dependent on gut microbiota 
↑ Firmicutes to Bacteroidetes ratio 
(146) 
Anti-epileptic: valproic acid  
 
 
Mice Prenatal ↑ Firmicutes to Bacteroidetes ratio in offspring 
↑ Caecal butyrate in male offspring 
Sex-specific impact 
(44) 
Anti-epileptic: valproic acid  
 
Mice Prenatal ↓ sensitivity to painful stimuli, ↑ sensitivity to non-
painful stimuli in offspring 
↓ Prepulse inhibition, social behavior, exploratory 
activity in offspring 
↑ locomotor and repetitive/stereotypic-like 
hyperactivity in offspring  
(65) 
Anti-epileptic: valproic acid  
 
Mice Prenatal ↓ Exploratory activity and social interaction in 
offspring 
↑ Interneuronal space in offspring 
↑ Neuroinflammation and neuronal disorganization 
in offspring 
(66) 
Antibiotics: Succinyl Sulfa 
Thiazole 
 
Female Rats Prenatal ↓ Social interaction, exploration in elevated plus 
maze in offspring 
↑ Anxiety in offspring 




pimaricin, acetic acid 
Female mice Prenatal ↓ Exploratory behavior with some persistence into 
postnatal weeks 7-8 
(48)  
Antibiotics: penicillin Mice Prenatal and 
Early 
Postnatal 
↓ Anxiety-like behavior in male offspring 
↓ Social behavior in offspring and social novelty 
↑ Aggression, reduced social avoidance in 
offspring 
Differences in composition and diversity 
↑ Brain cytokine expression 
















Antibiotics: various – 
penicillin, vancomycin, or 





↑ Adiposity  
↑ Firmicutes to Bacteroidetes ratio, 
Lachnospiracaeae 
Shift in microbiota composition  
(140) 
Antibiotics: vancomycin or 




Visceral hypersensitivity in males 
↓ Transient receptor potential in cation channel 
subfamily V member 1, alpha-2A adrenergic 
receptor, cholecystokinin B receptor 
Changes in gut microbiota composition 
(141) 
Antibiotics Humans Early 
Postnatal 
↓ Gut microbiota diversity noticeable after first 
year of life 
↓ Gut microbiota stability 
Transient increase in antibiotic resistant genes 
(137) 
Antibiotics Humans Early 
Postnatal 
↑ Risk of being overweight in later childhood in 
boys 










Postnatal Attenuated social-defeat stress specific decrease in 
Butyricimonas in susceptible mice 
Attenuated social-defeat stress specific increase in 
Deltaproteobacteria in susceptible mice 
(54) 
Antidepressant: 




Prenatal Change in gastrointestinal function, birth weight, 
metabolism, motor activity/development and 
weight in later life 
(57) 
Antidepressant: 





↓ Exploratory behavior 
↑ Anxiety in elevated plus maze 
↑ Latency in novelty suppressed feeding 
↓ Shock avoidance 
(144) 
Antidepressant: 
Selective Serotonin Reuptake 
Mice Early 
Postnatal 
↓ Exploratory behavior 


















sucrose preference test 
↑ Latency in novelty suppressed feeding 
↓ Shock avoidance 




Mice Postnatal ↑ Gut permeability, bacterial growth in small 
intestine 
↓ Operational taxonomic units of Firmicutes and ↑ 
in unknown bacteria, Verrucomicrobia, and 
Bacteroidetes in the caecum 
(59) 
Drugs of Abuse: 
Ethanol 
 
Rats Postnatal Changes in colonic microbiota composition 
(reduction in richness, evenness, Shannon 
diversity) 
(60) 
Drugs of Abuse: 
Ethanol 
 
Mice Postnatal ↑ Alistepes genus, ↓ Clostridium and alpha 
diversity 
Similar changes previously associated with 
inflammation 
(61) 








Mice Postnatal Intestinal depletion of bacteria enhances 
behavioral responses of cocaine  






Table 2. Impact of unhealthy maternal or adolescent diet. This table summarizes the effects of unhealthy prenatal and postnatal diet on 















Diet Model Treatment Start 
Time 
Effect of Diet  Reference 
Maternal high-fat diet 




Before mating ↓ Spirochetes (Treponoma spp and 
Sporobacter termitidis) which are involved in 
carbohydrate metabolism 
↓ Campylobacter in mother and offspring 
(74) 
Western Diet Mice 4 weeks old Compositional gut microbiota changes 
↑ Firmicutes/Bacteroidetes 
Ratio 
↑ Fat when microbiota transplanted into germ-
free mice 
(149) 




↓ Sex-specific differences in colonic gene 
expression involved in overlapping intestinal 
development pathways 
(75) 
High-fat diet (45% kcal 
from fat) 
Male Rats 4 weeks old ↑ Verrucomicrobia and Desulfovibrionaceae 
↑ Energy production and carbohydrate 
metabolism 
(72) 
Maternal high-fat diet 




8 weeks before 
mating 
↑ Social deficits, mediated by microbiota 
composition changes 
↓ Microbiota diversity in mother and offspring 
(73) 
Maternal high-fat diet 
(60% kcal from fat) 
Mouse 12-14 week diet 
before mating 




Maternal high-fat diet 
(60% kcal from fat) 
 
Mouse 7 weeks before 
mating 
↑ Nurr77 expression in males 

















Maternal high-fat diet 
(60% kcal from fat) 
 
Adult mice Start of 
pregnancy 
Abnormal hypothalamic gene expression 
No response to lipopolysaccharide 
Impaired post-stress response 
(79) 
Maternal Western diet Neonatal 
mice 
2 weeks before 
mating 
Toll-like receptor 2/4 mediated toxicity in 
neonate from breast milk 
(80) 
High-fat diet (45% kcal 
from fat) 
 
Mouse Post weaning ↑ adrenal gland weight in females/↓ in males 
↑ plasma corticosterone, glucocorticoid 
receptor levels in hypothalamus in females 
Sexually dimorphic effects in behavioral tests 
(150) 
 
High-fat diet (60% kcal 
from fat) 
 
Male rats Juvenile  ↓ Spatial memory 
↑ response to lipopolysaccharide-induced 
cytokines in hippocampus 
(151) 
High-fat diet (45% kcal 
from fat) 
 
Male mice  Binge eating 
during 
adolescence 
↑ Anxiety, cocaine self-administration in 
adulthood 
↑ Corticosterone during withdrawal 
↓ CB1, MOR expression in Nucleus 
Accumbens 
↑ GHSR in Ventral Tegmental Area 
(152) 
High trans-fatty acids Rats Gestational 
exposure 
↑ Serum endotoxins, hypothalamic cytokines 
in adulthood 
↑ Hypothalamic inflammation via NFκBp65 
in adulthood 
(76) 
















Figure 1.  Four “hits” programming for brain health  and disease. In addition to the three 
“hits” posited by Barker (prenatal and postnatal environment, genetic predisposition), we 
propose that the microbiota acts a fourth “hit”. The human microbiota is both influenced by and 
is also able to influence the other three factors. Together, these four “hits” can program for brain 
health and disease later in life. 
Figure 2. Overlap of critical periods in neurodevelopment with alterations in microbiota 
diversity. Maternal vaginal and intestinal microbiota diversity increases over the course of 
pregnancy, concurrently with cell birth and migration, as well as apoptosis. After birth, 
microbiota diversity has been measured to increase throughout infanthood. 
Figure 3. Prenatal and postnatal factors contribute to sex-specific programming of health 
in later life. The gut and vaginal microbiome of the mother is altered by diet, drugs, infection 
and stress. If birth occurs through vaginal delivery, the maternal vaginal microbiota colonizes the 
newborn’s gut. If Caesarean delivery occurs, the matern l skin microbiome colonizes the infant 
gut. Early in life, diet drugs and stress can also impact the infant microbiota composition. The 
microbiota is important for sex-specific microglial maturation, which is responsible for the 
neuroinflammatory response. The hypothalamic-pituitary-adrenal (HPA) axis is also influenced 
by and can influence the gut microbiota. Normally, it can attenuate the inflammatory response 
from the microglia. These four “hits” could affect this axis and affect brain health in later life. 
There are also other factors in adulthood that can impact brain health and disease (i.e. 
environment, disease, stress and sex).  
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